Author: [AUTHOR] Published on 3/1/2019 12:01:00 AM
Emmanuel Chigutsa, PhD, Senior Research Scientist, Pharmacometrics Team Leader, Eli Lilly and Company, Indianapolis, IN
Dr. Chigutsa has worked for Lilly Research Laboratories as a research scientist since 2013. His work there has given him diverse experiences. He has developed pharmacokinetic/pharmacodynamic (PK/PD) requirements for incorporation into program team strategies and created PK/PD sections of program plans. He has designed protocols and data requirements, including preparation of phase I–IV protocols. He manages and analyzes data and designs and conduct simulations to test study design assumptions. He works with several programs of PK/PD software. His work with for Eli Lilly and Company has led to publishing scientific articles and making technical presentations. It has even led to his work as a reviewer for several academic journals.
Dr. Chigutsa attended the University of Zimbabwe for both his Bachelors and Masters degrees in Pharmacy and Pharmacogenetics, respectively. He then went on to earn his doctorate in clinical pharmacology from the University of Cape Town. During his training he worked as the Pharmacist of Record for the UZ‐UCSF Collaborative Research Program in Harare, Zimbabwe. After earning his doctorate, he worked as a postdoctoral fellow at the University of Cape Town in South Africa.
In 2016, Dr. Chigutsa attended his first ASCPT Annual Meeting in San Diego. A work colleague recommended the Meeting to him and he “has not looked back since.” He enjoys his membership in ASCPT, particularly access to Clinical Pharmacology & Therapeutics and CPT: Pharmacometrics & Systems Pharmacology. They are high‐quality clinical pharmacology and pharmacometrics publications that he uses in his day‐to‐day work. He believes that through the journals, ASCPT has had a significant impact on the field. In his own work he often relies on published PK/PD models and other scientific work published in the journals to do his work.
Dr. Chigusta joined ASCPT in 2015.
